Coral Laboratories Limited (CORALAB.BO)
INR 688.65
(3.22%)
INR 688.65
(3.22%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 836.6 Million INR | 7.4% |
| 2022 | 778.93 Million INR | 6.38% |
| 2021 | 732.22 Million INR | -23.09% |
| 2020 | 952.05 Million INR | 39.49% |
| 2019 | 682.5 Million INR | -22.7% |
| 2018 | 882.98 Million INR | -1.75% |
| 2017 | 898.74 Million INR | -1.59% |
| 2016 | 913.25 Million INR | 24.28% |
| 2015 | 734.81 Million INR | 23.66% |
| 2014 | 594.2 Million INR | 16.97% |
| 2013 | 508.01 Million INR | 22.39% |
| 2012 | 415.07 Million INR | 3.87% |
| 2011 | 399.62 Million INR | 22.21% |
| 2010 | 326.98 Million INR | -3.81% |
| 2009 | 339.92 Million INR | -1.4% |
| 2008 | 344.73 Million INR | 5.59% |
| 2007 | 326.47 Million INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 316.55 Million INR | 9.59% |
| 2023 Q4 | 288.86 Million INR | 59.79% |
| 2023 Q3 | 180.78 Million INR | -21.91% |
| 2023 FY | 836.6 Million INR | 7.4% |
| 2023 Q1 | 135.47 Million INR | 20.82% |
| 2023 Q2 | 231.48 Million INR | 70.87% |
| 2022 Q1 | 162.54 Million INR | -8.1% |
| 2022 Q2 | 256.99 Million INR | 58.1% |
| 2022 Q3 | 247.26 Million INR | -3.79% |
| 2022 FY | 778.93 Million INR | 6.38% |
| 2022 Q4 | 112.12 Million INR | -54.65% |
| 2021 Q4 | 176.88 Million INR | 32.74% |
| 2021 Q1 | 237.89 Million INR | -10.07% |
| 2021 Q2 | 184.18 Million INR | -22.58% |
| 2021 Q3 | 133.25 Million INR | -27.65% |
| 2021 FY | 732.22 Million INR | -23.09% |
| 2020 Q1 | 222.81 Million INR | 22.27% |
| 2020 FY | 952.05 Million INR | 39.49% |
| 2020 Q4 | 264.53 Million INR | -6.65% |
| 2020 Q3 | 283.39 Million INR | 56.31% |
| 2020 Q2 | 181.3 Million INR | -18.63% |
| 2019 Q1 | 136.26 Million INR | -17.44% |
| 2019 Q2 | 165.08 Million INR | 21.16% |
| 2019 FY | 682.5 Million INR | -22.7% |
| 2019 Q3 | 198.93 Million INR | 20.5% |
| 2019 Q4 | 182.22 Million INR | -8.4% |
| 2018 Q2 | 256.46 Million INR | 13.03% |
| 2018 FY | 882.98 Million INR | -1.75% |
| 2018 Q4 | 165.04 Million INR | -29.64% |
| 2018 Q3 | 234.57 Million INR | -8.53% |
| 2018 Q1 | 226.9 Million INR | -15.04% |
| 2017 Q4 | 267.05 Million INR | 39.97% |
| 2017 FY | 898.74 Million INR | -1.59% |
| 2017 Q1 | 185.08 Million INR | -37.51% |
| 2017 Q2 | 281.8 Million INR | 52.26% |
| 2017 Q3 | 190.79 Million INR | -32.29% |
| 2016 Q1 | 185.9 Million INR | -19.68% |
| 2016 FY | 913.25 Million INR | 24.28% |
| 2016 Q3 | 250.8 Million INR | 13.07% |
| 2016 Q4 | 296.18 Million INR | 18.09% |
| 2016 Q2 | 221.8 Million INR | 19.31% |
| 2015 FY | 734.81 Million INR | 23.66% |
| 2015 Q4 | 231.46 Million INR | 16.78% |
| 2015 Q3 | 198.19 Million INR | 9.03% |
| 2015 Q1 | 151.4 Million INR | -18.87% |
| 2015 Q2 | 181.79 Million INR | 20.07% |
| 2014 Q2 | 151.64 Million INR | 28.5% |
| 2014 Q1 | 118.01 Million INR | -18.8% |
| 2014 FY | 594.2 Million INR | 16.97% |
| 2014 Q4 | 186.61 Million INR | 35.29% |
| 2014 Q3 | 137.93 Million INR | -9.04% |
| 2013 FY | 508.01 Million INR | 22.39% |
| 2013 Q2 | 123.75 Million INR | 0.34% |
| 2013 Q4 | 145.33 Million INR | 25.74% |
| 2013 Q3 | 115.58 Million INR | -6.6% |
| 2013 Q1 | 123.33 Million INR | -8.07% |
| 2012 Q3 | 92.61 Million INR | -11.11% |
| 2012 Q1 | 92.4 Million INR | -24.18% |
| 2012 Q2 | 104.18 Million INR | 12.75% |
| 2012 Q4 | 134.16 Million INR | 44.86% |
| 2012 FY | 415.07 Million INR | 3.87% |
| 2011 Q1 | 97.72 Million INR | 55.16% |
| 2011 Q4 | 121.87 Million INR | 36.36% |
| 2011 Q3 | 89.37 Million INR | -1.4% |
| 2011 Q2 | 90.64 Million INR | -7.24% |
| 2011 FY | 399.62 Million INR | 22.21% |
| 2010 Q3 | 70.97 Million INR | -26.04% |
| 2010 Q1 | 93.59 Million INR | 0.0% |
| 2010 FY | 326.98 Million INR | -3.81% |
| 2010 Q2 | 95.96 Million INR | 2.53% |
| 2010 Q4 | 62.98 Million INR | -11.26% |
| 2009 FY | 339.92 Million INR | -1.4% |
| 2008 FY | 344.73 Million INR | 5.59% |
| 2007 FY | 326.47 Million INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| ANG Lifesciences India Limited | 1.46 Billion INR | 42.741% |
| Bacil Pharma Limited | - INR | -Infinity% |
| BDH Industries Limited | 858.31 Million INR | 2.529% |
| Beryl Drugs Limited | 271.24 Million INR | -208.429% |
| Cian Healthcare Limited | 616.95 Million INR | -35.602% |
| Chemo Pharma Laboratories Limited | 18.38 Million INR | -4451.213% |
| Deccan Health Care Limited | 597.28 Million INR | -40.067% |
| DECIPHER LABS LIMITED | 362.75 Million INR | -130.626% |
| Add-Shop E-Retail Limited | 2.02 Billion INR | 58.601% |
| Concord Drugs Limited | 449.24 Million INR | -86.224% |
| Gujarat Terce Laboratories Limited | 479.74 Million INR | -74.384% |
| Gujarat Themis Biosyn Limited | 1.69 Billion INR | 50.736% |
| Hindustan Bio Sciences Limited | 10.48 Million INR | -7875.606% |
| Ishita Drugs and Industries Limited | 151.87 Million INR | -450.847% |
| Jenburkt Pharmaceuticals Limited | 1.41 Billion INR | 41.07% |
| KIMIA BIOSCIENCES LIMITED | 1.04 Billion INR | 20.23% |
| Kwality Pharmaceuticals Limited | 3.07 Billion INR | 72.764% |
| Makers Laboratories Limited | 1.03 Billion INR | 19.374% |
| Medi-Caps Limited | 265.63 Million INR | -214.945% |
| MedPlus Health Services Limited | 56.24 Billion INR | 98.513% |
| Panchsheel Organics Limited | 1.05 Billion INR | 20.489% |
| Parmax Pharma Limited | 154.24 Million INR | -442.392% |
| Parnax Lab Limited | 1.88 Billion INR | 55.667% |
| Patidar Buildcon Limited | 2.3 Million INR | -36148.007% |
| Phaarmasia Limited | 305.93 Million INR | -173.46% |
| PRAVEG LIMITED | 915.96 Million INR | 8.664% |
| Sunil Healthcare Limited | 901.91 Million INR | 7.242% |
| Syschem (India) Limited | 2.33 Billion INR | 64.176% |
| Sanjivani Paranteral Limited. | 536.87 Million INR | -55.83% |
| Sastasundar Ventures Limited | 13.56 Billion INR | 93.831% |
| SHAMROCK INDUSTRIAL CO.LTD. | 1.11 Million INR | -74730.411% |
| Smruthi Organics Limited | 1.27 Billion INR | 34.458% |
| Source Natural Foods and Herbal Supplements Limited | 272.96 Million INR | -206.484% |
| SUDARSHAN PHARMA INDUSTRIES LI | 4.63 Billion INR | 81.952% |
| Trident Lifeline Limited | 446.28 Million INR | -87.459% |
| Transchem Limited | 4.09 Million INR | -20304.981% |
| Trinity League India Limited | 2.95 Million INR | -28259.458% |
| Tyche Industries Limited | 696.83 Million INR | -20.057% |
| Vikram Thermo (India) Limited | 1.25 Billion INR | 33.291% |
| Vista Pharmaceuticals Limited | 102.87 Million INR | -713.2% |
| Vivanza Biosciences Limited | 278.89 Million INR | -199.974% |
| Zenith Healthcare Limited | 144.71 Million INR | -478.097% |
| Zenlabs Ethica Limited | 585.63 Million INR | -42.855% |
| Mercury Laboratories Limited | 755.59 Million INR | -10.722% |
| SHELTER PHARMA LIMITED | 400.22 Million INR | -109.031% |
| Vasundhara Rasayans Limited | 370.18 Million INR | -125.997% |
| Bharat Immunologicals & Biologicals Corporation Limited | 446.09 Million INR | -87.541% |
| Roopa Industries Limited | 715.53 Million INR | -16.92% |
| PANJON LTD. | 125.52 Million INR | -566.505% |
| Pharmaids Pharmaceuticals Limited | 151.12 Million INR | -453.599% |
| TIAAN CONSUMER LIMITED | - INR | -Infinity% |
| Anuh Pharma Limited | 6.47 Billion INR | 87.07% |
| Crestchem Limited | 212.56 Million INR | -293.581% |
| Emmessar Biotech & Nutrition Limited | 5.55 Million INR | -14968.516% |
| Sandu Pharmaceuticals Limited | 672.8 Million INR | -24.345% |
| Fredun Pharmaceuticals Limited | 3.48 Billion INR | 75.97% |
| Trimurthi Limited | 42.23 Million INR | -1880.69% |
| Shukra Pharmaceuticals Limited | 745.72 Million INR | -12.186% |
| Norris Medicines Limited | 56.35 Million INR | -1384.495% |
| Veerhealth Care Limited | 142.13 Million INR | -488.602% |
| Lactose (India) Limited | 1.13 Billion INR | 26.543% |
| OXYGENTA PHARMACEUTICAL LIMITE | 396.42 Million INR | -111.039% |
| Ambalal Sarabhai Enterprises Limited | 1.74 Billion INR | 52.01% |
| Gennex Laboratories Limited | 867.14 Million INR | 3.522% |
| Denis Chem Lab Limited | 1.67 Billion INR | 50.149% |
| Colinz Laboratories Limited | 70.29 Million INR | -1090.116% |
| Godavari Drugs Limited | 1.56 Billion INR | 46.615% |
| Zenotech Laboratories Limited | 368.08 Million INR | -127.283% |
| Shree Ganesh Remedies Limited | 1.25 Billion INR | 33.548% |
| Bharat Parenterals Limited | 2.59 Billion INR | 67.75% |
| Evoq Remedies Limited | 63.09 Million INR | -1226.049% |
| Kerala Ayurveda Limited | 1.02 Billion INR | 18.249% |
| KOBO BIOTECH LIMITED | - INR | -Infinity% |
| Natural Capsules Limited | 1.55 Billion INR | 46.171% |
| Auro Laboratories Limited | 526.99 Million INR | -58.75% |